Table 4.

Association between the relative expression of each gene and the development of a recurrence.

Gene	Relative expression mean ± SE		P-value
RECURRENCE
	NO	YES
	n = 47	n = 12
SNAI1	0.128± 0.053	0.183 ± 0.137	0.713
SNAI2	0.364 ± 0.140	0.257± 0.141	0.594
ESRP1	0.553 ± 0.103	0.495 ± 0.100	0.688
E-cadherin	1.433 ± 0.161	1.571 ± 0.278	0.673
RORC	2.020 ± 0.466	1.600 ± 0.307	0.455
VIM	5.888 ± 1.719	8.037 ± 4.541	0.665
N-cadherin	2.586 ± 0.593	1.632 ± 0.307	0.158
TWIST	0.025 ± 0.011	0.120 ± 0.101	0.368
SSTR2	0.131 ± 0.036	0.095 ± 0.053	0.581
SSTR3	0.645 ± 0.186	0.454 ± 0.141	0.418
SSTR5	0.098 ± 0.088	0.018 ± 0.016	0.374
DRD2 short isoform	1.834 ± 0.377	1.878 ± 0.545	0.948
DRD2 long isoform	2.075 ± 0.303	2.357 ± 0.714	0.721
ARRB1	0.775 ± 0.128	0.921 ± 0.206	0.554
PLAGL1	0.463 ± 0.173	0.328 ± 0.125	0.531
PEBP1	16.809 ± 1.153	20.827 ± 1.805	0.036
Ki-67	0.056 ± 0.016	0.038 ± 0.010	0.348
AIP	2.075 ± 0.104	2.184 ± 0.078	0.407
IN1-GHRL	0.045 ± 0.022	0.030 ± 0.006	0.509
KLK10	0.016 ± 0.005	0.014 ± 0.008	0.762
GHRL	0.034 ± 0.007	0.058 ± 0.017	0.215

P-value was calculated for each tumor characteristics (Student’s t test or Mann–Whitney U test, as appropriate). Significant p-values are shown in bold. SE, Standard Error.